Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

Overview of attention for article published in Journal of Clinical Oncology, October 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Dimensions has found 432 publications that cite this research output.

Article in Drug Delivery and Translational Research (April 2024)

Article in PLOS ONE (March 2024)

Article in Bioconjugate Chemistry (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.